Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins

Biochemical Pharmacology

Volumn 69, Issue 10, 2005, Pages 1493-1499

  Dautzenberg, Frank M ^a,b  

^a Axovan Ltd   (Switzerland)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Ca2+ stimulation; cAMP inhibition; Chimeric G protein; GTP S binding; Ligand binding

Indexed keywords

CALCIUM; CHIMERIC PROTEIN; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NANOPARTICLE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y2 RECEPTOR; RECOMBINANT RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL STIMULATION; CHIMERA; CONTROLLED STUDY; CYTOLOGY; FLUOROMETRY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SENSITIVITY ANALYSIS;

EID: 18044397679     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.02.014     Document Type: Article

References (33)

1. D.R. Gehlert Role of hypothalamic neuropeptide Y in feeding and obesity Neuropeptides 33 1999 329 338
2. H.A. Wieland, B.S. Hamilton, B. Krist, and H.N. Doods The role of NPY in metabolic homeostasis: implications for obesity therapy Expert Opin Investig Drugs 9 2000 1327 1346
3. A. Kask, J. Harro, S. von Horsten, J.P. Redrobe, Y. Dumont, and R. Quirion The neurocircuitry and receptor subtypes mediating anxiolytic-like effects on neuropeptide Y Neurosci Biobehav Rev 26 2002 259 283
4. A. Balasubramaniam Neuropeptide Y (NPY) family of hormones: progress in the development of receptor selective agonists and antagonists Curr Pharm Des 9 2003 1165 1175
5. N.R. Levens, and O. Della-Zuana Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs Curr Opin Invest Drugs 4 2003 1198 1204
6. S. Iyengar, D.L. Li, and RM.A. Simmons Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding? J Pharmacol Exp Ther 289 1999 1031 1040
7. A.G. Blomqvist, and H. Herzog Y-receptor subtypes - how many more? Trends Neurosci 20 1997 294 298
8. M.C. Michel, A.G. Beck-Sickinger, H. Cox, H.N. Doods, H. Herzog, and D. Larhammar XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors Pharmacol Rev 50 1998 143 150
9. Y. Dumont, D. Jacques, P. Bouchard, and R. Quirion Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains J Comp Neurol 402 1998 372 384
10. T. Kaga, M. Fujimiya, and A. Inui Emerging functions of neuropeptide Y Y(2) receptors in the brain Peptides 22 2001 501 506
11. P. Bonaventure, D. Nepomuceno, C. Mazur, B. Lord, D.A. Rudolph, and J.A. Jablonowski Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3- cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor J Pharmacol Exp Ther 308 2004 1130 1137
12. P. Naveilhan, H. Hassani, J.M. Canals, A.J. Ekstrand, A. Larefalk, and V. Chhajlani Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor Nat Med 5 1999 1188 1193
13. 3-36 physiologically inhibits food intake Nature 418 2002 650 654
14. R.L. Batterham, M.A. Cohen, S.M. Ellis, C.W. Le Roux, D.J. Withers, and G.S. Frost Bloom SR. Inhibition of food intake in obese subjects by peptide YY3-36 N Engl J Med 349 2003 941 948
15. F. Landolt "It's the chemistry, stupid!", or: the impact of early discovery patent applications on the drug development process Curr Top Med Chem 4 2004 601 608
16. Gerald C, Weinshank RL, Walker MW, Branchek T. Uses of nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors nucleic acid encoding. PCT Int. Appl. WO9521245, Synaptic Pharma Corp., USA, 1996.
17. Gerald C, Weinshank RL, Walker MW, Branchek T. DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof. PCT Int. Appl. US5989834, Synaptic Pharma Corp., USA, 1999.
18. Gerald C, Weinshank RL, Walker MW, Branchek T. Method of obtaining compositions comprising Y2 specific compounds. PCT Int. Appl. US6420532 (Synaptic Pharma Corp., USA) 2002.
19. Rist B, Zerbe O, Ingenhoven N, Scapozza L, Peers C, Vaughan PF, McDonald RL, Wieland HA, Beck-Sickinger AG. Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor. FEBS Lett 1996; 394:pp. 169-73.
20. N. Ingenhoven, C.P. Eckard, D.R. Gehlert, and A.G. Beck-Sickinger Molecular characterization of the human neuropeptide Y Y2-receptor Biochemistry 38 1999 6897 6902
21. Dautzenberg FM, Higelin J, Pflieger P, Neidhart W, Guba W. Establishment of robust functional assays for the characterization of Neuropeptide Y (NPY) receptors: identification of 3-(5-Benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist. Neuropharmacology, in press.
22. S. Rover, G. Adam, A.M. Cesura, G. Galley, F. Jenck, and F.J. Monsma Jr High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor J Med Chem 43 2000 1329 1338
23. F.M. Dautzenberg, J. Wichmann, J. Higelin, G. Py-Lang, C. Kratzeisen, and P. Malherbe Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo J Pharmacol Exp Ther 298 2001 812 819
24. 2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells Biochem Pharmacol 68 2004 1833 1844
25. E. Grouzmann, C. Meyer, E. Burki, and H. Brunner Neuropeptide Y Y2 receptor signalling mechanisms in the human glioblastoma cell line LN319 Peptides 22 2001 379 386
26. R.L. Batterham, and S.R. Bloom The gut hormone peptide YY regulates appetite Ann N Y Acad Sci 994 2003 162 168
27. 2 receptor antagonist Eur J Pharmacol 384 1999 3 5
28. J.A. Jablonowski, W. Chai, X. Li, D.A. Rudolph, W.V. Murray, and M.A. Youngman Novel non-peptidic neuropeptide Y Y2 receptor antagonists Bioorg Med Chem Lett 14 2004 1239 1242
29. S.P. Sheikh, M.M. O'Hare, O. Tortora, and T.W. Schwartz Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines J Biol Chem 264 1989 6648 6654
30. H.M. Cox, I.R. Tough, N. Ingenhoven, and A.G. Beck-Sickinger Structure-activity relationships with neuropeptide Y analogues: a comparison of human Y1-, Y2- and rat Y2-like systems Regul Pept 75-76 1998 3 8
31. Y. Shigeri, and M. Fujimoto Y2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line J Biol Chem 269 1994 8842 8848
32. P. Coward, S.D. Chan, H.G. Wada, G.M. Humphries, and B.R. Conklin Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors Anal Biochem 270 1999 242 248
33. S. An, T. Bleu, and Y. Zheng Transduction of intracellular calcium signals through G protein-mediated activation of phospholipase C by recombinant sphingosine 1-phosphate receptors Mol Pharmacol 55 1999 787 794